Investors chasing the quantum computing boom face a stark dilemma: two of the sector’s most prominent pure plays carry rich price tags and deepening financial risks heading into the back half of the decade.
IonQ (NYSE: IONQ) and D-Wave Quantum (NYSE: QBTS) are pursuing fundamentally different technological paths, giving the market two distinct bets on how commercial quantum computing eventually takes shape.
IonQ’s stock currently trades at a price-to-sales ratio of roughly 43, a level that signals the market has already baked in enormous revenue growth and an optimistic path to eventual profitability.
The company has attempted to justify that premium by lifting its full-year revenue guidance to a range of $280 million to $290 million, driven by expanding demand across commercial and international markets.
A significant driver of that upgraded outlook is IonQ’s July acquisition of SkyWater Technology, a deal that accounts for a large portion of the company’s anticipated 2026 revenue growth by fusing chip manufacturing capability with its quantum hardware development.
Yet the financial pressures underneath that headline growth are considerable, with operating losses continuing to widen as the company channels capital into research and development at an accelerating pace.
Share dilution compounds the concern, as the total number of IonQ shares outstanding has nearly doubled over the past five years, and further funding requirements could push that figure higher still.
D-Wave occupies a different corner of the market, distinguished as the only company currently selling both quantum annealers and the newer general-purpose gate-model systems that represent the industry’s longer-term frontier.
The company reported an error correction breakthrough in August 2026, a development that could strengthen its gate-model ambitions, though its revenues remain underwhelming and profit margins are deeply negative.
D-Wave does hold $588 million in cash and marketable securities, providing what the company describes as a multiyear operational runway, but an accumulated deficit of nearly $982 million as of late 2025 underscores the scale of losses sustained along the way.
Both companies also face competitive pressure from technology giants including IBM and Microsoft, which can absorb quantum research costs as part of vastly larger balance sheets, giving them staying power that smaller specialists cannot easily match.
The asymmetry between the established players and the pure plays is a central risk that separates quantum computing speculation from more conventional growth investing, where financial safety nets tend to be more visible.
For investors weighing exposure to the sector, neither company currently offers a clear path to profitability, and the question of which quantum architecture ultimately wins commercial adoption remains entirely open.
Splitting capital between the two offers diversification across competing technologies, but does not eliminate the fundamental uncertainty that defines this stage of the quantum computing market’s development.
